<DOC>
	<DOCNO>NCT00647907</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety Vfend treatment fungal infection</brief_summary>
	<brief_title>A Study Efficacy Safety Voriconazole Treatment Fungal Infections</brief_title>
	<detailed_description />
	<mesh_term>Mycoses</mesh_term>
	<mesh_term>Candidiasis</mesh_term>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Cryptococcosis</mesh_term>
	<mesh_term>Voriconazole</mesh_term>
	<criteria>Systemic invasive fungal infection Infection cause organism current treatment infection evidence failure and/or intolerance treatment approve antifungal agent Liver function test abnormalities Renal disease Fungal infection consider invasive systemic</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2011</verification_date>
</DOC>